Literature DB >> 15373979

[Club drugs: old medicines as new party drugs].

Sergio Abanades1, Ana M Peiró, Magí Farré.   

Abstract

During the last few years the term club drugs has been used for defining an heterogeneous group of chemical substances in permanent evolution, that are consumed for recreational purposes. These substances have been extensively used, firstly by the Rave culture and later by the so called Club culture. These movements are characterized by the search of amplified sensations, by means of the combination of electronic music, marathon dancing and substance abuse. After years with a predominating consumption of designer amphetamines in these groups, it seems that the use of another type of substances is increasing, fundamentally drugs with hallucinogenic effects. This review focus in four of these substances; ketamine, dextromethorphan, nitrous oxide and gamma-hydroxybutyric acid (GHB, liquid ecstasy), and includes a discussion of their pharmacology, recreational use, adverse effects and patient management. These drugs are, at he same time, drugs of abuse and medicines with concrete indications in therapeutics, with an important increase of their consumption in the last few years. The Rave and Club cultures are also described.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15373979     DOI: 10.1016/s0025-7753(04)74499-1

Source DB:  PubMed          Journal:  Med Clin (Barc)        ISSN: 0025-7753            Impact factor:   1.725


  3 in total

1.  Impulsivity and executive functions in polysubstance-using rave attenders.

Authors:  Antonio Verdejo-García; María Del Mar Sánchez-Fernández; Luisa María Alonso-Maroto; Fermín Fernández-Calderón; Jose C Perales; Oscar Lozano; Miguel Pérez-García
Journal:  Psychopharmacology (Berl)       Date:  2010-04-13       Impact factor: 4.530

2.  Ceftriaxone reverses ketamine-induced lasting EEG and astrocyte alterations in juvenile mice.

Authors:  K Dodman; R E Featherstone; J Bang; Y Liang; S J Siegel
Journal:  Drug Alcohol Depend       Date:  2015-09-21       Impact factor: 4.492

3.  Therapeutic Use of LSD in Psychiatry: A Systematic Review of Randomized-Controlled Clinical Trials.

Authors:  Juan José Fuentes; Francina Fonseca; Matilde Elices; Magí Farré; Marta Torrens
Journal:  Front Psychiatry       Date:  2020-01-21       Impact factor: 4.157

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.